HTX-011A
HTX-011-C2016-208
Phase 2 small_molecule completed
Quick answer
HTX-011A for Postoperative Pain is a Phase 2 program (small_molecule) at Heron Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Heron Therapeutics
- Indication
- Postoperative Pain
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed